플라보노이드 시장 보고서 : 유형별, 형태별, 용도별, 지역별(2025-2033년)

The global flavonoids market size reached USD 1.37 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.12 Billion by 2033, exhibiting a growth rate (CAGR) of 4.73% during 2025-2033.

Flavonoid is a natural polyphenolic compound with variable phenolic structures. It is a biologically active compound that adds pigment to fruits and vegetables, such as grapes, citrus fruits, peppers, onions, kale and dill. Chalcones, flavones, isoflavonoids, flavanones, anthoxanthins and anthocyanins are the commonly available flavonoids that are extracted from the barks, roots, stems and flowers of the plants. They are widely used as coloring and ultraviolet (UV) protection agents in functional food, dietary supplements and pharmaceutical and cosmetic products. They exhibit anti-aging, anti-edema, antioxidant and anti-inflammatory properties. Flavonoids smoothen and moisturize the skin, prevent the formation of wrinkles and promote collagen synthesis. They can also inhibit cancer cell growth, cure stomach ulcers and prevent infections in the body.

Flavonoids Market Trends:

Significant growth in the food and beverage industry across the globe is one of the key factors creating a positive outlook for the market. Anthocyanins and other flavonoids are widely used as coloring agents in ready-to-eat (RTE), packaged and processed food products. They are also added to pharmaceutical products and supplements due to their antibacterial, antifungal, antiviral and anticancer properties. Moreover, the increasing adoption of flavonoids for ruminant nutrition is providing a thrust to the market growth. They are used as feed additives to alter microbial activity, maintain pH balance and modify protein degeneration. Additionally, shifting consumer preference for premium-quality cosmetics and skin-care products is acting as another growth-inducing factor. Flavonoids are added to these products for protecting and reversing the damage caused by pollution, UV rays and sunlight on the skin. Other factors, including rising expenditure capacities of the consumers, along with extensive research and development (R&D) activities, are anticipated to drive the market toward growth.

Key Market Segmentation:

Breakup by Type:

• Anthocyanin
• Flavones
• Flavan-3-ols
• Flavonol
• Anthoxanthin
• Isoflavones
• Others

Breakup by Form:

• Powder
• Liquid

Breakup by Application:

• Food and Beverages
• Pharmaceutical
• Cosmetics
• Animal Feed
• Others

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Alchem International Pvt. Ltd., Bordas S.A., Cayman Chemical Company, Extrasynthese, Flavon Usa LLC, Indena S.p.A., INDOFINE Chemical Company Inc., Nutralliance, Merck KGaA and Quercis Pharma AG.

Key Questions Answered in This Report:

• How has the global flavonoids market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global flavonoids market?
• What are the key regional markets?
• What is the breakup of the market based on the type?
• What is the breakup of the market based on the form?
• What is the breakup of the market based on the application?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global flavonoids market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Flavonoids Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Anthocyanin
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Flavones
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Flavan-3-ols
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Flavonol
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Anthoxanthin
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Isoflavones
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast
• 6.7 Others
  • 6.7.1 Market Trends
  • 6.7.2 Market Forecast

7 Market Breakup by Form

• 7.1 Powder
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Liquid
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Application

• 8.1 Food and Beverages
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Pharmaceutical
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Cosmetics
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Animal Feed
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Alchem International Pvt. Ltd.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Bordas S.A.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Cayman Chemical Company
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Extrasynthese
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Flavon Usa LLC
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Indena S.p.A.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 SWOT Analysis
  • 14.3.7 INDOFINE Chemical Company Inc.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Nutralliance
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Merck KGaA
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Quercis Pharma AG
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio